Land: Australia
Språk: engelsk
Kilde: Department of Health (Therapeutic Goods Administration)
minocycline hydrochloride dihydrate, Quantity: 53.985 mg (Equivalent: minocycline, Qty 50 mg)
Aspen Pharma Pty Ltd
Tablet, film coated
Excipient Ingredients: lactose monohydrate; sodium starch glycollate; povidone; sorbitol; microcrystalline cellulose; stearic acid; magnesium stearate; titanium dioxide; hypromellose; sunset yellow FCF; quinoline yellow; light liquid paraffin; sodium lauryl sulfate
Oral
4 tablets, 60 tablets
(S4) Prescription Only Medicine
INDICATIONS AS AT 12 NOVEMBER 2003 : Minocycline may be used for the treatment of infections caused by any of the following organisms provided that they have been shown by bacteriological testing to be susceptible to minocycline: Escherichia coli, Enterobacter aerogenes, Haemophilus influenzae, Klebsiella and Proteus. It may also be used in the treatment of infections due to Streptococcus pyogenes (group A Beta-haemolytic) and Streptococcus faecalis but because a large proportion of these organisms are resistant to tetracyclines, minocycline should be used only if the orgaisms have been shown to be definitely sensitive. Tetracyclines, including minocycline, are not the drugs of choice in the treatment of staphylococcal infections. Minocycline may be considered for the treatment of such infections only if other suitable agents are not available and the organism has been shown to be sensitive to minocycline. Minocycline may be used in the treatment of tetracycline-resistant acne.
Visual Identification: Round, convex, orange film coated tablet with a scoreline on one side, and plain on the other.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius
Registered
1993-12-07
MINOMYCIN- Consumer Medicine Information Page 1 of 4 MINOMYCIN _minocycline _ CONSUMER MEDICINE INFORMATION (CMI) WHAT IS IN THIS LEAFLET This leaflet answers some common questions about MINOMYCIN. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking MINOMYCIN against the benefits this medicine is expected to have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT MINOMYCIN IS USED FOR The name of your medicine is MINOMYCIN. It contains the active ingredient minocycline hydrochloride. MINOMYCIN is used to treat acne, which is resistant to other antibiotics. It is also used to treat various other infections. MINOMYCIN belongs to a group of antibiotics called tetracyclines. They work by stopping the growth of bacteria. Your doctor may have prescribed MINOMYCIN for another purpose. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY IT HAS BEEN PRESCRIBED FOR YOU. Tetracyclines will not work against infections caused by viruses such as colds or flu. This medicine is available only with a doctor's prescription. MINOMYCIN is not addictive. BEFORE YOU TAKE IT _WHEN YOU MUST NOT TAKE IT _ DO NOT TAKE MINOMYCIN IF: 1. YOU HAVE EVER HAD AN ALLERGIC REACTION TO: • MINOCYCLINE, OR ANY OTHER TETRACYCLINE ANTIBIOTICS • ANY OF THE INGREDIENTS LISTED AT THE END OF THIS LEAFLET Some of the symptoms of an allergic reaction to a tetracycline may include rash, itching or hives on the skin; swelling of the face, lips, tongue or other parts of the body; shortness of breath, wheezing or difficulty breathing. 2. YOU ARE PREGNANT OR BREASTFEEDING. As with many medicines, tetracyclines may harm the developing or breastfeeding baby. This may include enamel loss and staining of the child's teeth. High doses of tetracyclines may also cause liver problems in pregnant women. Les hele dokumentet
Minomycin-PI 1 AUSTRALIAN PRODUCT INFORMATION MINOMYCIN (MINOCYCLINE HYDROCHLORIDE) TABLETS 1 NAME OF THE MEDICINE Minocycline hydrochloride 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each MINOMYCIN 50 mg tablet contains minocycline hydrochloride equivalent to 50 mg of minocycline Excipients of known effect: lactose monohydrate and sorbitol For the full list of excipients, see Section 6.1 List of excipients. 3 PHARMACEUTICAL FORM MINOMYCIN 50 minocycline 50mg (as hydrochloride) blister packs are presented as round, convex, orange film coated tablet, engraved "M50" on one side, the other plain. 4 CLINICAL PARTICULARS 4.1 T HERAPEUTIC INDICATIONS Minocycline may be used for the treatment of infections caused by any of the following organisms provided that they have been shown by bacteriological testing to be susceptible to minocycline: Escherichia coli, Enterobacter aerogenes, Haemophilus influenzae, Klebsiella and Proteus. It may also be used in the treatment of infections due to Streptococcus pyogenes (group A β - haemolytic) and Streptococcus faecalis but because a large proportion of these organisms is resistant to tetracyclines, minocycline should be used only if the organisms have been shown to be definitely sensitive. Tetracyclines, including minocycline, are not the drugs of choice in the treatment of staphylococcal infections. Minocycline may be considered for the treatment of such infections only if other suitable agents are not available and the organism has been shown to be sensitive to minocycline. Minocycline may be used in the treatment of tetracycline-resistant acne. 4.2 D OSE AND METHOD OF ADMINISTRATION The usual dosage of minocycline for adults is 200 mg initially, followed by 100 mg every 12 hours. Therapy should be continued for at least 24 to 48 hours after symptoms and fever have subsided. In tetracycline resistant acne, the dosage is 100 mg daily given preferably as 50 mg twice daily. Most cases are likely to resolve within 3 months. Minomycin-PI 2 RENAL IMPAIRMENT Patients with renal impai Les hele dokumentet